HAVCR2 and neoplasm: Notably, the morphological analysis demonstrated that TIM-3 was also present on CD68+ macrophages, CD31+ endothelial cells, CK-18+ epithelial cells, as well as on Bcl-2+ and PCNA+ tumor cells.